Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022767
Filing Date
2017-11-08
Accepted
2017-11-08 16:21:43
Documents
68
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q advm-10q_20170930.htm 10-Q 1473041
2 EX-12.1 advm-ex121_146.htm EX-12.1 183276
3 EX-31.1 advm-ex311_7.htm EX-31.1 15656
4 EX-31.2 advm-ex312_6.htm EX-31.2 15628
5 EX-32.1 advm-ex321_8.htm EX-32.1 8127
  Complete submission text file 0001564590-17-022767.txt   6860132

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT advm-20170930.xml EX-101.INS 1514063
7 XBRL TAXONOMY EXTENSION SCHEMA advm-20170930.xsd EX-101.SCH 55425
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE advm-20170930_cal.xml EX-101.CAL 54091
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE advm-20170930_def.xml EX-101.DEF 203334
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20170930_lab.xml EX-101.LAB 427648
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20170930_pre.xml EX-101.PRE 328025
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36579 | Film No.: 171186865
SIC: 2836 Biological Products, (No Diagnostic Substances)